Suzhou Junjing Biosciences Co., Ltd.
Clinical trials sponsored by Suzhou Junjing Biosciences Co., Ltd., explained in plain language.
-
Can a Once-Daily pill target Hard-to-Treat lung cancer?
Disease control Stopped earlyResearchers are testing an experimental daily capsule called AP-L1898 in adults with locally advanced or metastatic non-small cell lung cancer that cannot be treated with chemoradiotherapy. The study enrolls people whose cancer has worsened after standard treatment and whose tumo…
Phase 1/2 • Sponsor: Suzhou Junjing BioSciences Co., Ltd. • Aim: Disease control
Last updated Sep 12, 2026 00:00 UTC
-
Experimental cancer combo trial halted early – what we know
Disease control Stopped earlyThis early-phase trial tested an experimental drug called WJ05129, taken as a tablet, together with the chemotherapy drug paclitaxel in people with advanced solid tumors that had spread. The study aimed to find safe doses and check for side effects. Only 26 people were enrolled, …
Phase 1/2 • Sponsor: Suzhou Junjing BioSciences Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC
-
New lung cancer drug trial halted early – what we know
Disease control Stopped earlyThis study tested a new drug called WJ13405 in 14 people with advanced non-small cell lung cancer that had stopped responding to other treatments. The goal was to check safety, side effects, and how well the drug worked. However, the trial was terminated early, so results are lim…
Phase 1/2 • Sponsor: Suzhou Junjing BioSciences Co., Ltd. • Aim: Disease control
Last updated Jun 26, 2026 14:57 UTC